Filing Flows › Vycor Medical (VYCO) › Q4 2025
Vycor Medical (VYCO) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 31, 2026
Vycor Medical (VYCO) reported revenue of $417K for the fourth quarter 2025 (Q4 2025), -8% from a year earlier and -19% from the quarter before. Operating margin was -8.8%, net loss $63K (15.0% of revenue).
Vycor Medical, Q4 2025: revenue $417K (-8% year over year), operating margin -8.8%, net loss $63K, operating cash flow $39K. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $417K | -19% | -8% |
| Operating profit | −$37K | -214% | -289% |
| Net earnings | −$63K | -1370% | — |
| Operating cash flow | $39K | — | — |
| Free cash flow | $38K | — | — |
What changed
Revenue was $417K in Q4 2025, down 8% year over year and down 19% from the previous quarter. Vycor Medical Inc was the largest line at 97% of revenue.
Gross margin was 80.4%, down 6.8 points from Q4 2024. Operating costs exceeded revenue by $37K, an operating margin of -8.8%. Operating expenses fell 2% while revenue fell 8%. The quarter ended with a net loss of $63K, after a profit of $5K the previous quarter.
Operating cash flow was $39K. Non-cash charges added back $15K of depreciation and amortization. Working capital and other items added $87K. Capital expenditures of $2K left free cash flow of $38K.
Questions
What was Vycor Medical's revenue in the fourth quarter 2025?
Vycor Medical (VYCO) reported revenue of $417K for the fourth quarter 2025 (Q4 2025), -8% from a year earlier and -19% from the quarter before.
Was Vycor Medical profitable in the fourth quarter 2025?
Operating loss was $37K (-8.8% of revenue) and net loss $63K.
Source: Vycor Medical 10-K on SEC EDGAR.